China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.
The deal involves purchasing shares from seven entities.
The transaction is subject to board and shareholder approvals.
Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments